101400 — N Citron Balance Sheet
0.000.00%
- KR₩25bn
- KR₩14bn
- KR₩36bn
Annual balance sheet for N Citron, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5,773 | 23,642 | 16,982 | 25,827 | 15,339 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,029 | 2,888 | 5,773 | 4,787 | 6,667 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 9,365 | 29,173 | 26,734 | 34,525 | 25,349 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,655 | 725 | 769 | 1,313 | 7,015 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 28,800 | 35,087 | 37,203 | 45,885 | 48,478 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,675 | 14,469 | 7,714 | 7,836 | 6,407 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 11,378 | 15,220 | 8,236 | 8,512 | 10,405 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 17,421 | 19,867 | 28,968 | 37,373 | 38,073 |
Total Liabilities & Shareholders' Equity | 28,800 | 35,087 | 37,203 | 45,885 | 48,478 |
Total Common Shares Outstanding |